ParaZero Technologies Ltd. Announces Closing of $7.8 Million Initial Public Offering
July 31, 2023 09:38 ET
|
ParaZero Technologies Ltd.
KIRYAT ONO, ISRAEL, July 31, 2023 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (“ParaZero” or the “Company”) today announced the closing of its initial public offering of 1,950,000 ordinary shares...
Janover Inc. Announces Closing of $5.65 Million Initial Public Offering
July 27, 2023 16:05 ET
|
Janover Inc.
Boca Raton, FL, July 27, 2023 (GLOBE NEWSWIRE) -- Janover Inc. (Nasdaq: JNVR) (“Janover” or the “Company”), a B2B fintech marketplace connecting commercial property borrowers and lenders with a...
Medigus‘ Drones Safety Company, ParaZero (PRZO), to Commence Trading on Nasdaq Today
July 27, 2023 09:00 ET
|
Medigus Ltd
ParaZero Announces Initial Public Offering (IPO) Pricing of $7.8 million Tel Aviv, Israel, July 27, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in...
Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering
July 21, 2023 02:15 ET
|
Turnstone Biologics Corp.
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing new medicines to treat and cure...
60 Degrees Pharmaceuticals Announces Closing of Initial Public Offering
July 14, 2023 12:39 ET
|
Sixty Degrees Pharmaceuticals
WASHINGTON, July 14, 2023 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc., (NASDAQ: SXTP; SXTPW) (“60P” or the “Company”), specialists in developing and marketing medicines for infectious...
60 Degrees Pharmaceuticals Announces Pricing of Initial Public Offering
July 12, 2023 12:29 ET
|
Sixty Degrees Pharmaceuticals
WASHINGTON, July 12, 2023 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc., (NASDAQ: SXTP; SXTPW) ("60P" or the "Company"), specialists in developing and marketing medicines for infectious...
AI Therapeutics Announces Appointment of Biotechnology Industry Leader David Scheer as Chairman of the Board of Directors
July 12, 2023 11:45 ET
|
AI Therapeutics, Inc.
GUILFORD, Conn., July 12, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the appointment...
IX Acquisition Corp. Announces Fourth Extension of Deadline to Complete Initial Business Combination
July 11, 2023 18:05 ET
|
IX Acquisition Corp.
NEW YORK, July 11, 2023 (GLOBE NEWSWIRE) -- IX Acquisition Corp. (Nasdaq: IXAQ) (the “Company”) announced today that its board of directors (the “Board”) has decided to extend the date by which the...
ESH Acquisition Corp. Announces Closing of Initial Public Offering
June 28, 2023 14:46 ET
|
ESH ACQUISITION CORP.
Experienced leadership team seeking growing asset in the increasingly technology driven Entertainment, Sports, and Hospitality sectors NEW YORK, NEW YORK, June 28, 2023 (GLOBE...
Hairmax Featured on National TV Morning Show, Generates Over $275,000 in Revenue
June 28, 2023 08:59 ET
|
Hairmax
BOCA RATON, Fla., June 28, 2023 (GLOBE NEWSWIRE) -- On June 15th, Hairmax, the leader in transformative hair regrowth, was featured on one of the highest ranking syndicated, morning television shows...